Trump Survives Daily Media Onslaught, Still Has Higher

New Post Public Reply Private Reply Replies (3) Message Board
Lmcat
203
Trump Survives Daily Media Onslaught, Still Has Higher Approval Ratings Than Obama

Without question, President Donald Trump is attacked on a daily basis by the predominately liberal media that despise everything about him, many of whom are also unashamed to display their biased animosity toward the president.

Whether it be about alleged Russian collusion that still remains unverified after two years, wild speculation about a potential impeachment or coverage of both real and imagined “scandals,” the president is besieged by the media every day.

When the media isn’t discussing those issues, they routinely disparage and smear Trump as being a bigoted, racist, sexist, homophobic, Islamophobic xenophobe who is as corrupt as he is hateful, among whatever other various -ists and -phobes they can dredge up to use against him.


Yet, despite this constant onslaught from the liberal media, the president’s approval numbers remain high, higher, in fact, than those of his predecessor who was treated with kid gloves by an adoring media for eight years.

Rasmussen Reports noted that its Daily Presidential Tracking Poll showed that, as of Wednesday, Trump had an approval rating of 48 percent, as compared to a disapproval rating of 50 percent.

Interestingly, Trump’s 48 percent approval rating beats by three points the 45 percent approval rating held by former President Barack Obama at the same point in his presidency, Dec. 12, 2010 .


Furthermore, an interactive chart provided by Rasmussen, which compares the daily tracking numbers for both presidents show that Trump has had an approval rating either equal to or greater than Obama’s since around February of 2018.

Of those 48 percent who currently approve of the president’s job performance, 34 percent said they “Strongly Approve” of the job he is doing, while 41 percent of respondents said they “Strongly Disapprove” of Trump.

The difference between the “strong” approval and disapproval ratings is what Rasmussen refers to as the Presidential Approval Index, which in this case would be -7 points, and as it is linked to the daily tracking poll, it similarly shifts on a daily basis as well.

Just one day prior to Wednesday’s polling numbers, Trump’s approval index stood at a mere -3 points, as 36 percent “strongly approved” compared to only 39 percent who “strongly disapproved.”

Since February of this year, the worst approval index rating Trump has received was a -15 approval reached on July 18, in which Trump’s “strong” numbers were 31 percent approve and 46 percent disapprove, part of the overall rating of 44 percent approval and 54 percent disapproval on that day.

As per Obama’s approval index history, the former president stood at -15 points on the same Dec. 12 date in 2010, as only 24 percent “strongly approved” of his job performance while 39 percent “strongly disapproved” of the job he was doing. Obama’s overall approval numbers on that day were 45 percent approve and 53 percent disapprove.

However, that -15 was not the worst index rating Obama had received over a similar stretch of February to December, as Obama’s index numbers were routinely in the negative mid-teens and even topped -20 on numerous occasions, spiking at a downright terrible rating of -24 on Sept. 9, 2010.

To be sure, the two presidents are different men with vastly different governing styles facing different problems … but the biggest and most obvious difference between the two is the widely disparate treatment the two men have received from the mainstream media.

Obama was heralded and placed on a pedestal by the media, even as a significant margin of the nation remained staunchly opposed to his job performance and leftist agenda.

Trump is attacked and smeared by the media on a daily basis, yet roughly half the nation still stands beside him and approves of his conservative agenda and the job he continues to successfully do under withering media fire that likely would have already destroyed any other Republican president, and would have sunk Obama.

https://www.westernjournal.com/ct/trump-survi...tyalliance
Scroll down for more posts ▼

Top 10 Most Recent News Articles

New CMO Joins ARTHEx: Boosting Innovative RNA Focus

Updated Category News Views 26

ARTHEx Biotech's Strategic Expansion Looks like ARTHEx Biotech is shaking things up with some strategic moves by bringing in Dr. Christian Freitag as their new Chief Medical Officer. Now, if you’re knee-deep in the biotech game, you'll know that having someone like Freitag onboard is akin to adding a star player to your lineup. The guy's got more than two decades of...

Continue Reading
Zinzino's October Sales Report: Eye on the Nutritional Prize

Updated Category News Views 38

Delving Into Zinzino's October Performance Alright, let’s cut to the chase and dive headfirst into what really matters—Zinzino AB’s preliminary sales report for October 2026. If you’re banking on the thriving nutritional supplement sector, this Swedish company’s numbers might just be your radar’s blip. October wasn’t just any month for these folks; it was a...

Continue Reading
Are BWIN, LFCR, PCRX Shareholder Deals Fair?

Updated Category News Views 113

What's Really Going On with BWIN, LFCR, and PCRX? Everyone talks about when there's smoke, there's fire. But in this case, it’s hard not to wonder if we're standing knee-deep in burning embers, or just a dusty old campfire. Halper Sadeh LLC is ringing the alarm bells for Baldwin Group, Lifecore Biomedical, and Pacira BioSciences, the trio tagged under NASDAQ: BWIN,...

Continue Reading
Starting Pet End-of-Life Talks: Why Timing Matters

Updated Category News Views 23

Early Conversations Can Change Everything The minute you bring it up, let's be honest, nobody likes to talk about end-of-life decisions, not even for their pets. Yet, when you think about it, biding your time until things get critical isn't doing anyone any favors, especially not the furry ones. Drs. Brandon and Paola Beebout, two piercing minds from Kearney, Nebraska,...

Continue Reading
Kendra Scott's 'Long Live Joy' Campaign Dazzles

Updated Category News Views 40

Unveiling a Holiday Spectacle: 'Long Live Joy' Party hats off, folks, because Kendra Scott is stepping up the holiday game with something they’re calling 'Long Live Joy'. Now, we're not just talking about any run-of-the-mill marketing fluff. This one’s big, it’s colorful, and it’s here to make your accessorized holidays a tad more enchanting. The Multi-Faceted...

Continue Reading
RideNow Gears Up for Earnings Amidst Industry Shifts

Updated Category News Views 185

Highway to Earnings: RideNow's Third Quarter Call Alright, folks, this is the moment the powersports crowd has been itching for. RideNow Group, Inc. (NASDAQ: RDNW) is set to roll out their third-quarter financial results on November 10, 2026. If you're in for a wild ride—pun fully intended—mark this on your calendars. With this company hogging the spotlight in the...

Continue Reading
Duolingo Faces Class Action: Investors React Strongly

Updated Category News Views 63

Duolingo's Rough Road: A Lawsuit in Motion Alright, fasten your seatbelts, because we've got a real rollercoaster here with Duolingo (NASDAQ: DUOL). You know, the language-learning app that's been pushing ads like it's going out of style? Well, investors are seeing red—not the kind you want, either. This class action lawsuit looming over them is like an unwelcome...

Continue Reading
Crocs™ Gains C2C Circularity Gold for Classic Clogs

Updated Category News Views 81

Turning Plastic into Gold Well, folks, Crocs isn't just about comfort anymore. They're wrapping their iconic Classic Clog in a shiny new accolade: Cradle to Cradle Certified® Circularity Gold Version 5.0. Imagine that—an award for making something meant to last, designed to be repurposed. They're not just slapping new paint on the same old clogs either. This...

Continue Reading
Baidu Faces Fraud Allegations: What Investors Should Know

Updated Category News Views 196

Trouble on the Horizon for Baidu Shareholders If you've got a pulse in the world of stock trading, you've likely caught wind of the storm brewing over at Baidu, Inc. (NASDAQ: BIDU). We're talking some heavy-duty allegations of securities fraud, and a class action lawsuit that's got investors scrutinizing their portfolios like never before. The lawsuit's been filed in the...

Continue Reading
AllianceBernstein Unveils Income-Focused ETF Amid Volatile Times

Updated Category News Views 40

Diving into AllianceBernstein's New Income ETF Well, today we’ve got something stirring in the financial waters over at AllianceBernstein. They’ve launched a new exchange-traded fund (ETF), aptly named the AB Equity Premium Income ETF [INK]. Now, if you’re wondering what’s cooking with this newcomer on the NASDAQ, let’s crack it open and see what’s under the...

Continue Reading

Top 5 Most Recently Viewed Articles

Keyo Elevates Rudy Dajie to CEO, Driving Innovative Payments

Updated Category News Views 237

Keyo Appoints Rudy Dajie as New CEO for Advanced Payment Solutions Keyo has recently announced a game-changing leadership appointment with Rudy Dajie stepping into the role of Chief Executive Officer. In a world where artificial intelligence is rapidly evolving, the demand for enhanced security in biometric identification is greater than ever. Innovative Biometric...

Continue Reading
Final Call for $XPL Token Access: Join the XploraDEX Journey

Updated Category News Views 162

Final Chance to Participate in $XPL Token Distribution The $XPL token distribution is entering its crucial final phase, marking an exciting moment for both investors and traders. As the presale of XploraDEX nears its closing date, many are eager to grab their share of the tokens before the opportunity slips away. This innovative platform, set on the XRP Ledger, has the...

Continue Reading
Promising Small-Cap Stocks on the Rise for Investors

Updated Category News Views 73

Small-Cap Stocks on the Verge of Growth As 2024 progresses, many analysts have identified a resurgence in small-cap stocks, suggesting that this year could mark a turning point for these often-overlooked companies. With the economic landscape shifting, especially as interest rates stabilize, there is renewed hope for sectors that faced challenges in previous years....

Continue Reading
Eli Lilly's New Oral Diabetes Treatment Python Results Exceed Expectations

Updated Category News Views 204

Eli Lilly's Groundbreaking Diabetes Treatment Trials Eli Lilly and Company (NYSE: LLY) has made significant advancements in the treatment of type 2 diabetes with their oral medication, orforglipron. Recent Phase 3 trials, ACHIEVE-2 and ACHIEVE-5, have demonstrated impressive results in controlling blood sugar levels among participants. ACHIEVE Trials Overview The...

Continue Reading
Experience Luxury and Performance with the 2025 LC 500 Convertible

Updated Category News Views 63

Introducing the 2025 LC 500 Convertible The 2025 LC 500 Convertible marks another exciting development in the luxury automobile market, maintaining its prestige and allure. This model has undergone a few updates and is ready to impress enthusiasts and casual drivers alike. Standout Features of the 2025 Model This year's model comes with notable enhancements, including...

Continue Reading